Atypical left atrial flutter may occur as a complication after atrial fibrillation ablation, especially when linear and substrate ablation were initially deployed. In such cases, the most effective therapy is radiofrequency ablation, but the procedure can be long lasting and challenging. Use of multielectrode catheters and high-density mapping algorithms together with a conventional electrophysiological approach may shorten and simplify treatment. Case reportA 43-year-old woman, after previous ablations for atrial fibrillation and typical atrial flutter, was scheduled for another ablation, due to symptomatic atypical atrial flutter. Echocardiography showed left atrial (LA) diameter within the normal range (40 mm) and normal ejection fraction (65%).Previously the patient underwent circumferential pulmonary vein isolation and linear ablation with lines in the cavo-tricuspid isthmus (CTI), left atrial roof and mitral isthmus groove. During the last ablation, bi-directional block was confirmed in all locations and no arrhythmia was induced with aggressive stimulation during isoproterenol infusion.The ECG recorded on admission suggested left atrial flutter with 2:1 conduction, with positive F waves in leads II, III, aVF, and V1 and negative in leads aVR and AVL (Fig. 1). Intracardiac signals (IC) showed atrial flutter with CL 295-300 ms, with proximal and distal bipoles at the catheter placed in the coronary sinus (CS) activated simultaneously.Due to the electrographic pattern of arrhythmia and previous catheter ablations the operator (JK) decided to perform high-density mapping of left atrial endocardial activation using a multielectrode mapping (MEM) catheter (PentaRay, 20 poles, spacing 2-6-2, 1 mm width electrodes) and dedicated automatic algorithm[1] (Confidense, Carto 3 Biosense Webster).
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.